Legal Representation
Attorney
Martin L. Katz
Application History
21 events| Date | Code | Type | Description | Documents |
|---|---|---|---|---|
| Jun 20, 2005 | ABN2 | O | ABANDONMENT - FAILURE TO RESPOND OR LATE RESPONSE | Loading... |
| Jun 20, 2005 | MAB2 | O | ABANDONMENT NOTICE MAILED - FAILURE TO RESPOND | Loading... |
| Nov 9, 2004 | CNRT | W | SU - NON-FINAL ACTION - WRITTEN | Loading... |
| Nov 9, 2004 | CNRT | O | NON-FINAL ACTION MAILED | Loading... |
| Nov 3, 2004 | ACEC | I | AMENDMENT FROM APPLICANT ENTERED | Loading... |
| Oct 28, 2004 | DOCK | D | ASSIGNED TO EXAMINER | Loading... |
| Oct 27, 2004 | I | PAPER RECEIVED | Loading... | |
| Oct 27, 2004 | CRFA | I | CORRESPONDENCE RECEIVED IN LAW OFFICE | Loading... |
| Oct 20, 2004 | SUPC | I | STATEMENT OF USE PROCESSING COMPLETE | Loading... |
| Sep 3, 2004 | I | PAPER RECEIVED | Loading... | |
| Sep 3, 2004 | IUAF | S | USE AMENDMENT FILED | Loading... |
| Jul 13, 2004 | NOAM | O | NOA MAILED - SOU REQUIRED FROM APPLICANT | Loading... |
| Apr 20, 2004 | PUBO | A | PUBLISHED FOR OPPOSITION | Loading... |
| Mar 31, 2004 | NPUB | O | NOTICE OF PUBLICATION | Loading... |
| Mar 31, 2004 | NPUB | O | NOTICE OF PUBLICATION | Loading... |
| Feb 4, 2004 | CNSA | P | APPROVED FOR PUB - PRINCIPAL REGISTER | Loading... |
| Feb 3, 2004 | CNEA | O | EXAMINERS AMENDMENT MAILED | Loading... |
| Dec 22, 2003 | I | PAPER RECEIVED | Loading... | |
| Dec 22, 2003 | CRFA | I | CORRESPONDENCE RECEIVED IN LAW OFFICE | Loading... |
| Jul 30, 2003 | CNRT | F | NON-FINAL ACTION MAILED | Loading... |
| Jul 24, 2003 | DOCK | D | ASSIGNED TO EXAMINER | Loading... |
Detailed Classifications
Class 005
PHARMACEUTICAL PREPARATIONS FOR THE TREATMENT OF CARDIOVASCULAR, VASCULAR AND RELATED INFLAMMATORY DISEASES
First Use Anywhere:
May 16, 2003
First Use in Commerce:
May 16, 2003
Additional Information
Pseudo Mark
ENCYSIVE PHARMACEUTICALS INCORPORATED
Classification
International Classes
005
Disclaimers
The following terms have been disclaimed and are not claimed as part of the trademark:
General Disclaimer
PHARMACEUTICALS INC.